BR9908713A - Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos - Google Patents

Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos

Info

Publication number
BR9908713A
BR9908713A BR9908713-8A BR9908713A BR9908713A BR 9908713 A BR9908713 A BR 9908713A BR 9908713 A BR9908713 A BR 9908713A BR 9908713 A BR9908713 A BR 9908713A
Authority
BR
Brazil
Prior art keywords
selegiline
burns
demethyl
treat wounds
dermatological
Prior art date
Application number
BR9908713-8A
Other languages
English (en)
Inventor
Mark G Resnick
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of BR9908713A publication Critical patent/BR9908713A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

<B>USO DE SELEGILINA OU DESMETIL-SELEGILINA PARA TRATAMENTO DE FERIDAS, QUEIMADURAS E DANOS DERMATOLóGICOS<D> A presente invenção está direcionada aos métodos que podem ser usados no tratamento de feridas, queimaduras e pele fotodanificada. Os métodos podem ser usados tanto por humanos como por animais e envolvem a administração de composições contendo selegilina e/ou desmetil-selegilina.
BR9908713-8A 1998-03-16 1999-03-03 Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos BR9908713A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7804398P 1998-03-16 1998-03-16
PCT/US1999/004588 WO1999047133A1 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Publications (1)

Publication Number Publication Date
BR9908713A true BR9908713A (pt) 2000-11-21

Family

ID=22141568

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908713-8A BR9908713A (pt) 1998-03-16 1999-03-03 Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos

Country Status (13)

Country Link
US (3) US6461619B1 (pt)
EP (1) EP1063981B1 (pt)
CN (1) CN1154484C (pt)
AT (1) ATE222101T1 (pt)
AU (1) AU750909B2 (pt)
BR (1) BR9908713A (pt)
CA (1) CA2322878C (pt)
DE (1) DE69902520T2 (pt)
DK (1) DK1063981T3 (pt)
ES (1) ES2178405T3 (pt)
HK (1) HK1037980A1 (pt)
IL (2) IL138290A0 (pt)
WO (1) WO1999047133A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
DE69902520T2 (de) 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
AU8679801A (en) * 2000-08-28 2002-03-22 Somerset Pharmaceuticals Inc Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
JP2005536449A (ja) * 2001-12-18 2005-12-02 ブラシカ・ファウンデーション・ケモプロテクション・リサーチ，インコーポレイテッド グルタチオンおよび第２相解毒酵素による酸化ストレス障害の予防および治療
DE10229456A1 (de) * 2002-07-01 2004-02-05 Wank, Rudolf, Prof. Dr.med. Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US20090075860A1 (en) * 2005-04-28 2009-03-19 Japan Science And Technology Agency Transdermal absorption enhancer
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
US20090324693A1 (en) * 2008-06-30 2009-12-31 Kimberly-Clark Worldwide, Inc. Delivery Product for Topical Compositions
WO2012051374A2 (en) * 2010-10-15 2012-04-19 The Procter & Gamble Company Use of monoamine oxidase inhibitors to improve epithelial biology
WO2012082950A2 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
IT201800006455A1 (it) * 2018-06-19 2019-12-19 Nuovo utilizzo degli inibitori della monoammino ossidasi B

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3764144D1 (de) 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
EP0252290B1 (en) 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US4868218A (en) 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5783606A (en) * 1995-02-10 1998-07-21 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5266332A (en) 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH &amp; Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5242950A (en) 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5354885A (en) 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
CN100360123C (zh) * 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
CA2244253C (en) * 1996-03-15 2002-11-12 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neuropathy by administering selegiline
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
DE69902520T2 (de) * 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden

Also Published As

Publication number Publication date
IL138290A (en) 2010-05-17
US20040180009A1 (en) 2004-09-16
IL138290A0 (en) 2001-10-31
DK1063981T3 (da) 2002-10-14
EP1063981A1 (en) 2001-01-03
AU750909B2 (en) 2002-08-01
CA2322878C (en) 2008-05-06
DE69902520T2 (de) 2003-04-10
US20030021833A1 (en) 2003-01-30
WO1999047133A1 (en) 1999-09-23
ES2178405T3 (es) 2002-12-16
US6709664B2 (en) 2004-03-23
AU2979199A (en) 1999-10-11
CA2322878A1 (en) 1999-09-23
DE69902520D1 (de) 2002-09-19
US6461619B1 (en) 2002-10-08
CN1154484C (zh) 2004-06-23
HK1037980A1 (en) 2002-03-01
ATE222101T1 (de) 2002-08-15
US7147864B2 (en) 2006-12-12
EP1063981B1 (en) 2002-08-14
CN1300209A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
BR9908713A (pt) Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
ES2185050T3 (es) Utilizacion de la octoxiglicerina en una composicion cosmetica y/o dermatologica como agente activo para el tratamiento de la seborrea y/o del acne.
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
BR9407560A (pt) Copolimeros elastômeros termoplásticos enxertados com silicone e composiçoes para tratamento dos cabelos e da pele contendo estes copolimeros
BR0003897A (pt) Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
AU2002342765A1 (en) Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
EP1262177A3 (en) Medical use of thyromimetic compounds to treat hair loss and compositions
DE69731477D1 (de) Mittel zur akne behandlung
PT1235571E (pt) Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
GEP20063828B (en) Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents
BR0200921A (pt) Uso de produtos de legume para o tratamento de agressões externas
ES2153412T3 (es) Agente externo para la piel.
BR9810981A (pt) Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
BR9903751A (pt) Composição para uso cosmético e/ou dermatológico, utilização cosmética da composição, utilização da composição e utilização de pelo menos um ácido aminossulfÈnico n-substituìdo
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
BR9916535A (pt) Utilização de pelo menos um material nãosaponificável de óleo vegetal, e, métodos detratamento cosmético das cicatrizes da pele,mucosas vizinhas e/ou fâneros, do envelhecimentointrìnseco das cicatrizes da pele,das mucosas vizinhase/ou fâneros, de tratamento cosmético da pele,mucosas vizinhas e/ou fâneros, tendo sidosubmetidos a uma radiação actìnica, e, depilatórioda pele
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
RU94024337A (ru) Антиметастатическое средство
ES2188754T3 (es) Componente b como cicatrizante.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/137, A61P 17/02

Ipc: A61K 31/137 (2007.10), A61P 17/02 (2007.10)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O, 10, ( VIII ) DA LPI.

B15V Prolongation of time limit allowed

Free format text: DEVOLUCAO DE PRAZO CONCEDIDA - RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 15 DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.